PROCTER & GAMBLE HEALTH | VIVO BIO TECH | PROCTER & GAMBLE HEALTH/ VIVO BIO TECH |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 17.4 | 198.6% | View Chart |
P/BV | x | 10.6 | 1.3 | 815.2% | View Chart |
Dividend Yield | % | 2.0 | 0.0 | - |
PROCTER & GAMBLE HEALTH VIVO BIO TECH |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
VIVO BIO TECH Mar-23 |
PROCTER & GAMBLE HEALTH/ VIVO BIO TECH |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 52 | 10,338.3% | |
Low | Rs | 3,883 | 18 | 21,441.2% | |
Sales per share (Unadj.) | Rs | 740.7 | 35.1 | 2,113.1% | |
Earnings per share (Unadj.) | Rs | 138.2 | 1.8 | 7,775.4% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 8.0 | 1,940.3% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0 | - | |
Avg Dividend yield | % | 2.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 447.6 | 34.8 | 1,285.7% | |
Shares outstanding (eoy) | m | 16.60 | 14.90 | 111.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 1.0 | 625.0% | |
Avg P/E ratio | x | 33.5 | 19.7 | 169.9% | |
P/CF ratio (eoy) | x | 29.8 | 4.4 | 680.6% | |
Price / Book Value ratio | x | 10.3 | 1.0 | 1,027.2% | |
Dividend payout | % | 68.7 | 0 | - | |
Avg Mkt Cap | Rs m | 76,761 | 522 | 14,713.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 135 | 1,524.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 522 | 2,354.2% | |
Other income | Rs m | 184 | 0 | 51,083.3% | |
Total revenues | Rs m | 12,480 | 523 | 2,387.8% | |
Gross profit | Rs m | 3,247 | 218 | 1,486.8% | |
Depreciation | Rs m | 281 | 93 | 303.3% | |
Interest | Rs m | 8 | 80 | 9.6% | |
Profit before tax | Rs m | 3,142 | 46 | 6,799.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 20 | 4,296.7% | |
Profit after tax | Rs m | 2,295 | 26 | 8,662.5% | |
Gross profit margin | % | 26.4 | 41.8 | 63.2% | |
Effective tax rate | % | 27.0 | 42.7 | 63.2% | |
Net profit margin | % | 18.7 | 5.1 | 367.9% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 318 | 3,684.3% | |
Current liabilities | Rs m | 6,791 | 250 | 2,719.7% | |
Net working cap to sales | % | 40.0 | 13.1 | 306.5% | |
Current ratio | x | 1.7 | 1.3 | 135.5% | |
Inventory Days | Days | 263 | 0 | - | |
Debtors Days | Days | 343 | 865 | 39.7% | |
Net fixed assets | Rs m | 10,617 | 908 | 1,169.7% | |
Share capital | Rs m | 166 | 149 | 111.4% | |
"Free" reserves | Rs m | 7,265 | 370 | 1,965.0% | |
Net worth | Rs m | 7,431 | 519 | 1,432.4% | |
Long term debt | Rs m | 0 | 431 | 0.0% | |
Total assets | Rs m | 22,330 | 1,230 | 1,814.9% | |
Interest coverage | x | 409.1 | 1.6 | 25,911.7% | |
Debt to equity ratio | x | 0 | 0.8 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.4 | 129.7% | |
Return on assets | % | 10.3 | 8.6 | 119.3% | |
Return on equity | % | 30.9 | 5.1 | 604.7% | |
Return on capital | % | 42.4 | 13.3 | 319.3% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 13.1 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | 1,605 | NA | - | |
Fx inflow | Rs m | 1,465 | 54 | 2,733.6% | |
Fx outflow | Rs m | 1,605 | 4 | 40,135.0% | |
Net fx | Rs m | -140 | 50 | -282.7% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 148 | 1,590.9% | |
From Investments | Rs m | -215 | -40 | 537.8% | |
From Financial Activity | Rs m | -985 | -112 | 881.2% | |
Net Cashflow | Rs m | 1,160 | -3 | -34,227.1% |
Indian Promoters | % | 0.0 | 42.1 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 0.0 | - | |
FIIs | % | 6.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 57.9 | 83.2% | |
Shareholders | 56,778 | 18,971 | 299.3% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | SUNSHINE FAC | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | 0.13% | 0.45% |
1-Month | -1.15% | 2.83% | 2.55% |
1-Year | 0.73% | 73.57% | 56.14% |
3-Year CAGR | -8.76% | -12.17% | 15.22% |
5-Year CAGR | 4.97% | -2.06% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the SUNSHINE FAC share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of SUNSHINE FAC the stake stands at 42.1%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of SUNSHINE FAC.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
SUNSHINE FAC paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of SUNSHINE FAC.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.